Northwest Healthcare Properties REIT Delivers Strong Q3 2025 Results and Advances Portfolio Strategy

Executive Summary

• Northwest Healthcare Properties REIT reported a material turnaround, posting Q3 2025 net income of $31.2 M versus a $157.3 M loss in the same quarter‑previous year.
• AFFO increased to $0.11 per unit (up from $0.09 in Q2 2025) with an 85% payout ratio, and leverage improved to 48.4% of assets.
• The REIT announced a conditional NZ$214 M internalization of Vital management rights (expected net proceeds > US$300 M) and outlined its Normal Course Issuer Bid (NCIB) to repurchase up to $24 M principal of convertible debentures and 22.2 M units.

Key Details

• Revenue: $104.3 M for Q3 2025, down 2.6% YoY due mainly to disposals of non‑core assets.
• Same‑Property NOI (SPNOI): $76.9 M, up 4.4% YoY; regional growth: NA +2.9%, Brazil +4.6%, Europe +4.8%, Australasia +5.1%.
• Net Income: $31.2 M (vs. a loss of $157.3 M in Q3 2024).
• AFFO: $0.11 per unit; payout ratio 85% (down from 99% YoY).
• Fair‑Value Gains on Properties: $8.8 M (vs. $94.7 M loss in Q3 2024).
• Leverage: Debt/GBV = 48.4% (down from 50.0%).
• Liquidity: Approx. $250 M cash + credit facility capacity.
• Disposition Proceeds: $35.3 M generated during the quarter; remaining assets held for sale valued at $79.7 M.
• Financing Activity: Re‑financed European & Canadian mortgages; $20.9 M of Canadian mortgages maturing 2025 to be repaid via revolving credit facility.
• Vital Internalization: Conditional agreement for NZ$214 M (≈US$170 M) purchase; contingent on lender consent, regulatory approvals, and Vital equity raise ≥NZ$175 M. Vital completed a NZ$190 M equity placement on Nov 11 2025; closing expected Dec 31 2025 (or Q1 2026). Anticipated net proceeds > US$300 M.
• NCIB Details: Up to $15.515 M of Series H debentures, $8.625 M of Series I debentures, and 22,177,862 units (≈10% of each class) may be repurchased over the next 12 months; daily purchase caps applied; funding from available liquidity.
• Healthscope Update: Receiver‑led sale process underway; rent deferral arrangement ended Oct 31 2025 with full repayment plus interest.
• Operational Metrics: Occupancy 96.9%; WALE 13.4 years; gross leasable area 15.7 M sf across 167 properties.

Notable Quotes

“Our portfolio continues to benefit from the strong tailwinds supporting the healthcare infrastructure sector… The internalization of Vital and the active exploration of alternatives for our European portfolio demonstrate the actions we are taking to reduce costs, streamline operations and reallocate capital back to North America…” – Zach Vaughan, CEO

Materiality Assessment: Material – Positive (significant earnings reversal, improved leverage, large prospective proceeds from Vital transaction, and active share repurchase program).